Dr Reddy’s, FDC Recall Products In US Over Mfg Issues

New Delhi: Dr Reddy’s Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according to the US health regulator.As per the latest Enforcement Report by Food and Drug Administration (USFDA), the US-based subsidiary of Dr Reddy's Laboratories is recalling multiple strengths of Morphine Sulfate extended-release tablets in the US. The medication is used to relieve severe and persistent pain.